Vaxcyte Rg
PCVX
USD
STOCK MARKET:
NMS
Open
 
...
Large gap with delayed quotes
Last quote
04/27/2026 - 16:18:06
Bid
04/27/2026 - 16:28:28
Bid
Volume
Ask
04/27/2026 - 16:28:28
Ask
Volume
60.025
+0.535 ( +0.90% )
60.07
300
60.55
200
More information
Analysis by TheScreener
24.04.2026
Evaluation Neutral  
Interest Strong  
Sensibility Middle  
Analysis date: 24.04.2026
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 31.03.2026.
Interest
  Strong
Three stars since 03.04.2026.
Earnings Rev Trend
  0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 28.11.2025 at a price of 49.61.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 31.03.2026.
4wk Rel Perf
  -0.47%
 
The four-week dividend-adjusted performance versus SP500 is .
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 31.03.2026.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.26%.
Mkt Cap in $bn
  8.56
With a market capitalization >$8bn, VAXCYTE is considered a large-cap stock.
G/PE Ratio
  0.23
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
  -51.06
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
  11.77%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
  8
Over the last seven weeks, an average of 8 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  125
For 1% of index variation, the stock varies on average by 1.25%.
Correlation
  0.29
Stock movements are strongly independent of index variations.
Value at Risk
  14.28
The value at risk is estimated at USD 14.28. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  01.12.2023